John Lue

700 total citations
16 papers, 481 citations indexed

About

John Lue is a scholar working on Ophthalmology, Dermatology and Immunology. According to data from OpenAlex, John Lue has authored 16 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Ophthalmology, 4 papers in Dermatology and 4 papers in Immunology. Recurrent topics in John Lue's work include Glaucoma and retinal disorders (9 papers), Retinal Diseases and Treatments (6 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). John Lue is often cited by papers focused on Glaucoma and retinal disorders (9 papers), Retinal Diseases and Treatments (6 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). John Lue collaborates with scholars based in United States, Ireland and Germany. John Lue's co-authors include John Sefton, John R. Gibson, Deborah A. Lew‐Kaya, Gerald D. Weinstein, Nicholas J. Lowe, Gary D. Novack, David J. Friedman, Edward Shmunes, Eduardo Tschen and Joseph L. Jorizzo and has published in prestigious journals such as Ophthalmology, Journal of the American Academy of Dermatology and American Journal of Ophthalmology.

In The Last Decade

John Lue

16 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Lue United States 11 209 202 135 118 98 16 481
Wannita Klinngam United States 12 31 0.1× 41 0.2× 50 0.4× 66 0.6× 136 1.4× 16 321
Timothy P. Kingston United Kingdom 10 123 0.6× 76 0.4× 9 0.1× 99 0.8× 16 0.2× 21 282
Kazuhide Oshiden Japan 7 92 0.4× 16 0.1× 163 1.2× 61 0.5× 381 3.9× 8 531
Delphine Compan France 11 278 1.3× 102 0.5× 5 0.0× 94 0.8× 12 0.1× 11 450
Wenwen Xue China 13 14 0.1× 31 0.2× 116 0.9× 262 2.2× 78 0.8× 41 545
Zainab Jiyad United Kingdom 9 167 0.8× 70 0.3× 9 0.1× 45 0.4× 21 0.2× 21 452
Deborah A. Lew‐Kaya United States 11 572 2.7× 432 2.1× 3 0.0× 259 2.2× 35 0.4× 22 818
Silada Kanokrungsee Thailand 11 246 1.2× 42 0.2× 8 0.1× 19 0.2× 24 0.2× 35 358
R.C.M. Kiekens Netherlands 10 246 1.2× 256 1.3× 2 0.0× 82 0.7× 62 0.6× 10 526
Matteo Auriemma Italy 11 139 0.7× 129 0.6× 3 0.0× 61 0.5× 13 0.1× 20 373

Countries citing papers authored by John Lue

Since Specialization
Citations

This map shows the geographic impact of John Lue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lue more than expected).

Fields of papers citing papers by John Lue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lue. The network helps show where John Lue may publish in the future.

Co-authorship network of co-authors of John Lue

This figure shows the co-authorship network connecting the top 25 collaborators of John Lue. A scholar is included among the top collaborators of John Lue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lue. John Lue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Lew‐Kaya, Deborah A., John Lue, John Sefton, & Patricia Walker. (2004). Evaluating psoriasis severity: limitations of the PASI and advantages of the overall lesional assessment. Journal of the American Academy of Dermatology. 50(3). P153–P153. 5 indexed citations
3.
Koo, John, Nicholas J. Lowe, Deborah A. Lew‐Kaya, et al.. (2000). Tazarotene plus UVB phototherapy in the treatment of psoriasis. Journal of the American Academy of Dermatology. 43(5). 821–828. 58 indexed citations
4.
Sefton, John, et al.. (2000). Photodamage pilot study: A double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel. Journal of the American Academy of Dermatology. 43(4). 656–663. 39 indexed citations
5.
Krueger, Gerald G., Lynn A. Drake, Peter M. Elias, et al.. (1998). The Safety and Efficacy of Tazarotene Gel, a Topical Acetylenic Retinoid, in the Treatment of Psoriasis. Archives of Dermatology. 134(1). 57–57. 42 indexed citations
6.
Weinstein, Gerald D., Gerald G. Krueger, Nicholas J. Lowe, et al.. (1997). Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. Journal of the American Academy of Dermatology. 37(1). 85–92. 131 indexed citations
7.
Koch, Douglas D., et al.. (1997). Levobunolol 0.5% and timolol 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy. Journal of Cataract & Refractive Surgery. 23(7). 1075–1080. 15 indexed citations
8.
Behrens‐Baumann, W., Friedemann Kimmich, John G. Walt, & John Lue. (1994). A Comparison of the Ocular Hypotensive Efficacy and Systemic Safety of 0.5% Levobunolol and 2% Carteolol. Ophthalmologica. 208(1). 32–36. 6 indexed citations
9.
Stewart, William C., et al.. (1992). A Comparison of the Ocular Hypotensive Efficacy of Twice-Daily 0.25% Levobunolol to 0.5% Timolol in Patients Previously Treated with 0.5% Timolol. Journal of Glaucoma. 1(4). 237–242. 3 indexed citations
10.
Silverstone, David E., et al.. (1991). Evaluation of Once-Daily Levobunolol 0.25% and Timolol 0.25% Therapy for Increased Intraocular Pressure. American Journal of Ophthalmology. 112(1). 56–60. 18 indexed citations
11.
Melamed, Shlomo, John Cohen, George L. Spaeth, et al.. (1989). A Comparison of the Ocular Hypotensive Efficacy of Once-daily and Twice-daily Levobunolol Treatment. Ophthalmology. 96(1). 8–11. 21 indexed citations
12.
Cohen, John, et al.. (1987). Glaucoma Treatment With Once-Daily Levobunolol. American Journal of Ophthalmology. 104(4). 443–444. 6 indexed citations
13.
14.
Lewis, Richard A., John Lue, Gary D. Novack, et al.. (1986). Glaucoma Treatment With Once-Daily Levobunolol. American Journal of Ophthalmology. 101(3). 298–304. 44 indexed citations
15.
Galin, Miles A., A Cinotti, W. Morton Grant, et al.. (1985). Levobunolol vs Timolol for Open-Angle Glaucoma and Ocular Hypertension. American Journal of Ophthalmology. 99(1). 11–17. 32 indexed citations
16.
Dermer, Gerald B., John Lue, & Harry B. Neustein. (1974). Comparison of surface material, cytoplasmic filaments, and intercellular junctions from untransformed and two mouse sarcoma virus-transformed cell lines.. PubMed. 34(1). 31–8. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wannita Klinngam Breakdown of academic impact, for papers by Timothy P. Kingston Breakdown of academic impact, for papers by Kazuhide Oshiden Breakdown of academic impact, for papers by Delphine Compan Breakdown of academic impact, for papers by Wenwen Xue Breakdown of academic impact, for papers by Zainab Jiyad Breakdown of academic impact, for papers by Deborah A. Lew‐Kaya Breakdown of academic impact, for papers by Silada Kanokrungsee Breakdown of academic impact, for papers by R.C.M. Kiekens Breakdown of academic impact, for papers by Matteo Auriemma
Rankless by CCL
2026